Lena Lenhammar
Uppsala University(SE)
Publications by Year
Research Areas
Immune cells in cancer, Antibiotic Resistance in Bacteria, Immune Cell Function and Interaction, Ferroptosis and cancer prognosis, Chemokine receptors and signaling
Most-Cited Works
- → Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against Acinetobacter baumannii and Pseudomonas aeruginosa(2023)51 cited
- → Tricyclic Antidepressants Inhibit Opioid Receptor Binding in Human Brain and Hepatic Morphine Glucuronidation(1994)44 cited
- → The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation(2017)29 cited
- → Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing(2018)20 cited
- → Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition(2019)18 cited
- → Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death(2023)18 cited
- → Mebendazole is unique among tubulin-active drugs in activating the MEK–ERK pathway(2020)17 cited
- → Design, synthesis and in vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB)(2016)15 cited
- → Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment(2024)1 cited